Evidence check: ApoB in the context of longevity

ApoB (Apolipoprotein B) is a core component of atherogenic lipoproteins (LDL, VLDL) and is considered one of the strongest predictors of cardiovascular events. In longevity research, ApoB is relevant because elevated levels are directly linked to atherosclerosis, heart attack, and stroke – diseases that shorten lifespan. The evidence is human-strong: numerous prospective cohort studies and Mendelian randomization analyses demonstrate a causal relationship between ApoB and cardiovascular mortality. Unlike LDL cholesterol alone, ApoB captures the total number of atherogenic particles and is often more informative. The provided context lacks direct information on ApoB, so this answer relies on established scientific knowledge. For longevity, a low ApoB level (< 0.9 g/L in high-risk patients) is desirable, but always within the overall risk profile. Caveat: single measurements can be affected by inflammation or metabolic states; clinical decisions should be based on multiple values. MyBody-X offers ApoB in its blood test – the measurement is validated, but interpretation should be done by a physician.